Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
07/1997
07/29/1997US5652243 Modulating cellular response
07/29/1997US5651980 Methods of use of uncoated gel particles
07/29/1997US5651973 Therapeutically effective topical application of ST1435
07/24/1997WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026265A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
07/24/1997WO1997026264A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
07/24/1997WO1997025961A1 Bowman-birk inhibitor for male sexual dysfunction
07/24/1997CA2241567A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
07/24/1997CA2241565A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
07/23/1997EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus
07/23/1997EP0784980A1 Collagen hydrolysis accelerator
07/23/1997EP0784672A1 Human inositol monophosphatase h1
07/23/1997EP0784467A1 Unitary vaginal dosage form useful as a local contraceptive and/or for combatting sexually transmitted diseases and/or hiv
07/23/1997EP0540717B1 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS
07/22/1997US5650414 Pyrazolopyridines or imidazolopyridines
07/22/1997US5650394 Use of urinastatin-like compounds to prevent premature delivery
07/17/1997WO1997025620A1 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility
07/17/1997WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
07/17/1997WO1997025038A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy
07/17/1997WO1997025037A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
07/17/1997WO1997025036A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
07/17/1997WO1997025035A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
07/17/1997CA2241623A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
07/17/1997CA2241559A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
07/17/1997CA2241556A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
07/17/1997CA2241519A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy
07/16/1997EP0783571A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors
07/16/1997EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin
07/16/1997EP0783310A1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies
07/16/1997EP0672056B1 Calcium channel blocking polypeptides from filistata hibernalis
07/16/1997EP0580624B1 Novel cytarabine derivatives, their production and use
07/16/1997CN1154699A (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
07/15/1997US5648478 Tissue-specific enhancer active in prostate
07/15/1997US5648386 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
07/10/1997WO1997024334A1 Benzimidazole derivatives
07/10/1997DE19548332A1 Hormonpflaster Hormone patches
07/09/1997CN1154067A Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri
07/08/1997US5646308 Benzopyran derivatives
07/08/1997US5646143 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
07/08/1997CA2131888C Chlorine dioxide containing composition for prevention and treatment of bacterial infections
07/03/1997WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
07/03/1997WO1997023508A1 Compounds with growth hormone releasing properties
07/03/1997WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
07/03/1997WO1997023485A1 Heteroarylcarboxamide derivatives
07/03/1997WO1997023462A1 Quinoline and quinazoline compounds useful in therapy
07/03/1997WO1997023453A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
07/03/1997WO1997023228A2 Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
07/03/1997WO1997023227A1 Transdermal estradiol/progestogen agent patch and its production
07/03/1997CA2241192A1 Contraceptive process and kit for female mammals that consists of a combination of gestagen and estrogen
07/03/1997CA2241011A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
07/03/1997CA2239711A1 Compounds with growth hormone releasing properties
07/03/1997CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
07/03/1997CA2239010A1 Transdermal estradiol/progestogen agent patch and its production
07/03/1997CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
07/02/1997EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents
07/02/1997EP0781280A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
07/02/1997EP0781268A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
07/02/1997EP0781126A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
07/02/1997CN1153473A Use of droloxifene for treatment of cardiovascular diseases
07/01/1997US5644055 Cyclization of indole or quinoline compound, enzyme inhibitors, treatment of cardiovasacular disorders
07/01/1997US5643932 Superoxide radical inhibitor
07/01/1997US5643930 6-heterocyclic-4-amino-1,3,4,5,-tetrahydrobenz [cd]indoles
07/01/1997US5643896 2-Benzyl-3-arylbenzothiophenes
07/01/1997US5643578 Subunit vaccines
07/01/1997CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins
06/1997
06/26/1997WO1997022372A1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body
06/26/1997WO1997022334A1 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
06/26/1997DE19549264A1 Verfahren und Kit zur Kontrazeption Method and kit for contraception
06/26/1997DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
06/25/1997EP0780397A2 New 17alpha-Cyanomethylestra-4,9-dien-derivatives, a process for the production of these compounds and pharmaceutical compositions containing them
06/25/1997EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions
06/25/1997EP0779889A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE
06/25/1997EP0779817A1 Enteral vaccine for vaginal infections
06/25/1997CN1152868A Use of droloxidfene for the treatment of cardiovascular diseases
06/25/1997CN1152450A Oral capsule Xianglianzi for contraception made of traditional Chinese medicine
06/24/1997US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same
06/24/1997US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same
06/24/1997US5641797 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd] indoles
06/24/1997US5641792 Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them
06/24/1997US5641779 Selective ligands of 5-HT1D -5-HT1B receptors derived from indolepiperazine which are useful medicaments
06/24/1997US5641752 Methods of using endothelin antagonists
06/24/1997US5641669 Platelet-activating factor acetylhydrolase
06/24/1997US5641517 Composition comprising fertilized shell eggs
06/24/1997US5641487 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
06/22/1997CA2193610A1 17 .alpha.-cyanomethylestra-4, 9-dien derivative compounds, processes for making same and pharmaceutical compositions containing same
06/19/1997WO1997021707A1 Antagonists of gonadotropin releasing hormone
06/19/1997WO1997021704A1 Antagonists of gonadotropin releasing hormone
06/19/1997WO1997021703A1 Antagonists of gonadotropin releasing hormone
06/19/1997WO1997021439A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness
06/19/1997WO1997021435A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2240115A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2240111A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2240108A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2240048A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2211161A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness
06/18/1997EP0779284A1 Novel 2-naphthamide derivatives and their use in therapy as D3 receptor agonists